Related Experiment Video
Updated: Nov 5, 2025

11:34
A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
549
Tolerogenic dendritic cells suppress titanium particle-induced inflammation
Wenzhao Wang1,2, Bing Han3,4, Jianan Chen3
1Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Experimental and Therapeutic Medicine
|May 19, 2021
Summary
Tolerogenic dendritic cells (tolDCs) effectively reduced titanium particle-induced inflammation in a mouse model. This study suggests tolDCs offer a potential therapeutic strategy for preventing or treating inflammation caused by prosthetic joint wear debris.
Area of Science:
- Biomedical Engineering
- Immunology
- Materials Science
Background:
- Aseptic loosening is a primary complication in prosthetic joint surgery, often caused by wear debris like titanium particles.
- Dendritic cells (DCs) are key immune cells involved in initiating and progressing inflammatory responses.
- Tolerogenic dendritic cells (tolDCs) represent a potential therapeutic approach for inflammatory conditions.
Purpose of the Study:
- To investigate the efficacy of tolDCs in mitigating titanium particle-induced inflammation.
- To explore the underlying mechanisms by which tolDCs exert their anti-inflammatory effects.
Main Methods:
- An air-pouch mouse model was used to study titanium particle-induced inflammation.
- Pro-inflammatory cytokine levels were measured to assess inflammation.
- In vitro studies were conducted to analyze the release of anti-inflammatory cytokines by tolDCs.
Main Results:
- Tolerogenic dendritic cells significantly inhibited titanium particle-induced inflammation in the mouse model.
- This inhibition was associated with a decrease in pro-inflammatory cytokines.
- In vitro, tolDCs released anti-inflammatory cytokines, including interleukin-10, protecting against inflammation.
Conclusions:
- Tolerogenic dendritic cells demonstrate a significant role in suppressing titanium particle-induced inflammation.
- These findings highlight tolDCs as a promising alternative for preventing or treating inflammation associated with prosthetic joint wear particles.

